Active Ingredient: BISMUTH SUBCITRATE POTASSIUM; METRONIDAZOLE; TETRACYCLINE HYDROCHLORIDE
Proprietary Name: BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: 140MG;125MG;125MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A217511
Product Number: 001
Approval Date: Jul 3, 2023
Applicant Holder Full Name: RICONPHARMA LLC
Marketing Status:
Prescription
Patent and Exclusivity Information
